Shares of Applied DNA Sciences, Inc. (APDN) are surging more than 18% Wednesday morning after the company established a SARS-CoV-2 mutations and variants tracking program teaming up with Northwell Health.
The companies have entered into a pro bono Material Transfer Agreement (MTA).
As per the program, de-identified positive Covid-19 specimens supplied by Northwell are being screened for SARS-CoV-2 mutations found in currently known variants of concern (VoCs) using Applied DNA's Linea Covid-19 Assay Kit and Selective Genomic Surveillance Mutation Panel.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.